chemical structure of tirzepatide Antidiabetic drug molecular structure, illustration - Stock Image - C059/2723 TIRZEPATIDE

GLP-1R activation, depicted in blue, exerts a broad spectrum of effects spanning multiple organ systems

40,41 A study using nationwide registers in Nordic countries showed that with an additional adjustment for laboratory results (glycated hemoglobin, albuminuria, eGFR), there was no difference in the risk of AF between SGLT2i users and GLP-1RA users in Swedish cohort (HR=0.90 [95% CI: 0.79 to 1.01]) and in Danish cohort (HR=0.92 [95% CI: 0.79 to 1.08])

J.ChristiansenE.TikhonovaI

It collects information on adverse effects of medicines under theYellow Card system, where patients are invited to submit their experience

This guide covers every vitamin and mineral that matters during GLP-1 therapy

For example, Hosseini et al